This strong impact on the MCC cell lines is not observed with idelalisib treatment rendering PI3K p110δ expression and/or function less important for cell viability and for the PI3K pathway function of almost all MCC cell lines tested as shown by the unaltered pAKT concentration. The gene discussed is PIK3CD; the disease is Merkel cell skin cancer.